Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MV still open to acquisition despite calling off Acron merger talks

This article was originally published in Clinica

Executive Summary

Molecular Vision (MV) announced last week that it had ceased discussions with its Swiss development partner Acrongenomics over a potential merger. The two companies had agreed in November 2007 to MV becoming a wholly-owned subsidiary of Acron and that the transaction was to be completed at the end of January. However, the deadline has since been extended twice, and while Acron acquired a 10.9% stake in MV in February 2008, a full acquisition was not completed as expected at the end of March. Dr Campbell told Clinica that by dropping the deal, both companies are able to concentrate on their respective activities "without being clouded by the takeover discussion". However, he did not reject the possibility of picking up merger discussions with Acron, or with other potential suitors, in the future. The breakdown of the merger talks will not affect the existing R&D agreement between the two companies to develop low-cost, readily portable POC diagnostics using MV's proprietary light emitting based (LEP)-based detector technology.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel